This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Zhuhai Essex Bio-Pharmaceutical Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Zhenheng Wang: Innovator in Pharmaceutical Development
Introduction
Zhenheng Wang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of recombinant human-basic fibroblast growth factor (rh-bFGF). His work has implications for various medical applications, showcasing his expertise and innovative spirit.
Latest Patents
Zhenheng Wang holds a patent for a mutated nucleic acid molecule of recombinant human-basic fibroblast growth factor (rh-bFGF) and a pharmaceutical composition comprising rh-bFGF. This invention provides a novel approach to utilizing rh-bFGF, along with its pharmaceutical applications, which can enhance therapeutic outcomes.
Career Highlights
Wang is currently associated with Zhuhai Essex Bio-Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work at this company reflects his commitment to improving healthcare through innovative solutions.
Collaborations
Zhenheng Wang has collaborated with notable colleagues, including Yingluo Xiong and Xinzhi Wang. These partnerships have likely contributed to the success of his projects and the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Zhenheng Wang's contributions to the field of pharmaceuticals, particularly through his patent on rh-bFGF, highlight his role as an innovator. His work continues to impact the medical community positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile